TTRX Stock Analysis: Buy, Sell, or Hold?
$3.49
-0.11 (-3.06%)
▼
5d:
+2.35%
30d:
+8.39%
90d:
-23.63%
BUY
MODERATE Confidence
Analysis Updated: Apr 28, 2026 12:00 AM ET
Earnings: May 13, 2026
13d
Get Alerted When TTRX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: TTRX shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
💡 BUY OPPORTUNITY: TTRX shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: TTRX is currently trading at $3.49, which is considered slightly high relative to its 30-day fair value range of $3.28 to $3.52.
Technical Outlook: Technically, TTRX is in a downtrend. Immediate support is located at $3.15, while resistance sits at $3.70. Short-term momentum is weak, with the stock down 3.1% recently.
Market Sentiment: TTRX has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $8.00 (+122.2%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, TTRX is in a downtrend. Immediate support is located at $3.15, while resistance sits at $3.70. Short-term momentum is weak, with the stock down 3.1% recently.
Market Sentiment: TTRX has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $8.00 (+122.2%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$3.28 -
$3.52
Company Quality Score
59/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
73.7%
All Signals
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-3.1%)
- BULLISH: Trading 122.2% below Wall St target ($8.00)
Trading Range Analysis
30-Day Trading Range
$3.28 -
$3.52
Current vs Trading Range
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$3.15
Resistance Level
$3.70
Current Trend
Downtrend
Technical data as of
Apr 28, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-24.00
Wall Street Target
$8.00
(+122.2%)
Share & Embed Analysis
Last updated: April 29, 2026 9:52 AM ET
Data refreshes hourly during market hours. Next update: 10:52 AM
Data refreshes hourly during market hours. Next update: 10:52 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is TTRX showing a specific setup today?
Insider Activity (6 Months)
6
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Zuraiz Chaudhary
BUY
2500 shares
2025-12-12
Arthur F Golden
BUY
9868 shares
2025-11-24
Arthur F Golden
BUY
20532 shares
2025-11-21
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$25 | 53 HOLD |
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$408 | 52 HOLD |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$224 | 64 BUY |
|
CRNX
Crinetics Pharmaceutical… |
STRONG BUY
17 analysts |
$84 | 49 HOLD |
|
INCY
Incyte Corporation |
HOLD
27 analysts |
$107 | 50 HOLD |